Prevalence of current tobacco use, females in Andorra
Andorra: Prevalence of current tobacco use, females was 36.4% in 2024. ▲ Rising
Prevalence of current tobacco use, females in Andorra, 2000–2024
Source: Global Health Observatory Data Repository, World Health Organization (WHO). Measured in % of female adults.
Analysis
In 2024, prevalence of current tobacco use, females in Andorra stood at 36.4%. That is the highest value across all 9 years on record.
The figure is up 1.1% on the previous year and up 9.6% over ten years.
Over the whole period, prevalence of current tobacco use, females in Andorra peaked at 36.4% in 2024 and was at its lowest, 28.8%, in 2000.
That places Andorra 5th out of 166 countries with data for 2024, putting it in the top 10%.
Prevalence of current tobacco use, females in Andorra, year by year
| Year | % of female adults | Change |
|---|---|---|
| 2000 | 28.8% | — |
| 2005 | 30.0% | +4.2% |
| 2007 | 30.7% | +2.3% |
| 2010 | 31.6% | +2.9% |
| 2015 | 33.2% | +5.1% |
| 2020 | 34.9% | +5.1% |
| 2022 | 35.7% | +2.3% |
| 2023 | 36.0% | +0.8% |
| 2024 | 36.4% | +1.1% |
Andorra compared with similar countries
- Andorra's 36.4% is above the median for high income countries, which is 17.4%, 2.1× the median. (57 countries reporting)
- Andorra's 36.4% is above the median for Europe & Central Asia, which is 19.9%, 1.8× the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 29.8% | 28.8% | 30.7% | 3 |
| 2010s | 32.4% | 31.6% | 33.2% | 2 |
| 2020s | 35.8% | 34.9% | 36.4% | 4 |
Countries ranked near Andorra
More health data for Andorra
- Estimated changes in temperature-related death rates compared to projected death rates 1,824 deaths per 1,000 people (2090)
- Heat deaths vs projected death rates, annual growth rate 0.0878 % change on previous year (2090)
- Un projection of annual infant deaths, annual growth rate -100 % change on previous year (2077)
- Number of infants who die before age 1 0 deaths (2100)
- Age population, age 07, female, interpolated 296 (2025)
- Age population, age 09, male, interpolated 371 (2025)
- Age population, age 09, female, interpolated 345 (2025)
- Age population, age 08, male, interpolated 358 (2025)
- Age population, age 08, female, interpolated 329 (2025)
- Age population, age 07, male, interpolated 329 (2025)
Frequently asked questions
- What is prevalence of current tobacco use, females in Andorra?
- Prevalence of current tobacco use, females in Andorra was 36.4% in 2024, according to Global Health Observatory Data Repository, World Health Organization (WHO).
- What is the highest prevalence of current tobacco use, females recorded in Andorra?
- The highest recorded value was 36.4% in 2024.
- What is the lowest prevalence of current tobacco use, females recorded in Andorra?
- The lowest recorded value was 28.8% in 2000.
- How does Andorra rank for prevalence of current tobacco use, females?
- Andorra ranks 5th out of 166 countries with data for 2024.
- Is prevalence of current tobacco use, females rising or falling in Andorra?
- Over the last ten years it is up 9.6%. The long-run trend across the full record is rising.
- Where does this Andorra data come from?
- The figures come from Global Health Observatory Data Repository, World Health Organization (WHO), published as part of Prevalence of current tobacco use, females (% of female adults). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 9 observations, free to reuse under CC BY 4.0 (World Bank Open Data).
About this data
The percentage of the female population ages 15 years and over who currently use any tobacco product (smoked and/or smokeless tobacco) on a daily or non-daily basis. Tobacco products include cigarettes, pipes, cigars, cigarillos, waterpipes (hookah, shisha), bidis, kretek, heated tobacco products, and all forms of smokeless (oral and nasal) tobacco. Tobacco products exclude e-cigarettes (which do not contain tobacco), “e-cigars”, “e-hookahs”, JUUL and “e-pipes”. The rates are age-standardized to the WHO Standard Population.